nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—Niacin—atherosclerosis	0.784	1	CrCtD
Metyrapone—ABCC3—Ezetimibe—atherosclerosis	0.114	0.703	CbGbCtD
Metyrapone—CYP3A4—Rosuvastatin—atherosclerosis	0.0102	0.0624	CbGbCtD
Metyrapone—CYP3A4—Ezetimibe—atherosclerosis	0.0102	0.0624	CbGbCtD
Metyrapone—CYP3A4—Simvastatin—atherosclerosis	0.00944	0.058	CbGbCtD
Metyrapone—CYP3A4—Pravastatin—atherosclerosis	0.00924	0.0568	CbGbCtD
Metyrapone—CYP3A4—Lovastatin—atherosclerosis	0.00924	0.0568	CbGbCtD
Metyrapone—Endocrine disorder—Simvastatin—atherosclerosis	0.000827	0.059	CcSEcCtD
Metyrapone—Abdominal discomfort—Lovastatin—atherosclerosis	0.000441	0.0314	CcSEcCtD
Metyrapone—Abdominal discomfort—Simvastatin—atherosclerosis	0.000412	0.0294	CcSEcCtD
Metyrapone—Angiopathy—Ezetimibe—atherosclerosis	0.000328	0.0234	CcSEcCtD
Metyrapone—Alopecia—Lovastatin—atherosclerosis	0.000325	0.0232	CcSEcCtD
Metyrapone—Alopecia—Ezetimibe—atherosclerosis	0.000319	0.0228	CcSEcCtD
Metyrapone—Alopecia—Simvastatin—atherosclerosis	0.000304	0.0217	CcSEcCtD
Metyrapone—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000303	0.0216	CcSEcCtD
Metyrapone—Angiopathy—Niacin—atherosclerosis	0.000287	0.0205	CcSEcCtD
Metyrapone—Alopecia—Niacin—atherosclerosis	0.000279	0.0199	CcSEcCtD
Metyrapone—Alopecia—Pravastatin—atherosclerosis	0.000275	0.0196	CcSEcCtD
Metyrapone—Hypertension—Ezetimibe—atherosclerosis	0.000271	0.0194	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000266	0.019	CcSEcCtD
Metyrapone—Pain—Rosuvastatin—atherosclerosis	0.000264	0.0188	CcSEcCtD
Metyrapone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000252	0.018	CcSEcCtD
Metyrapone—Nervous system disorder—Ezetimibe—atherosclerosis	0.000252	0.0179	CcSEcCtD
Metyrapone—Skin disorder—Ezetimibe—atherosclerosis	0.000249	0.0178	CcSEcCtD
Metyrapone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000244	0.0174	CcSEcCtD
Metyrapone—Hypertension—Pravastatin—atherosclerosis	0.000234	0.0167	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000233	0.0166	CcSEcCtD
Metyrapone—Pain—Lovastatin—atherosclerosis	0.000224	0.016	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000221	0.0158	CcSEcCtD
Metyrapone—Pain—Ezetimibe—atherosclerosis	0.000219	0.0156	CcSEcCtD
Metyrapone—Skin disorder—Niacin—atherosclerosis	0.000218	0.0156	CcSEcCtD
Metyrapone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000214	0.0153	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000211	0.0151	CcSEcCtD
Metyrapone—Hypotension—Niacin—atherosclerosis	0.00021	0.015	CcSEcCtD
Metyrapone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00021	0.015	CcSEcCtD
Metyrapone—Pain—Simvastatin—atherosclerosis	0.000209	0.0149	CcSEcCtD
Metyrapone—Abdominal pain—Lovastatin—atherosclerosis	0.000207	0.0147	CcSEcCtD
Metyrapone—Dizziness—Rosuvastatin—atherosclerosis	0.000204	0.0146	CcSEcCtD
Metyrapone—Abdominal pain—Ezetimibe—atherosclerosis	0.000203	0.0145	CcSEcCtD
Metyrapone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0002	0.0143	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000194	0.0138	CcSEcCtD
Metyrapone—Abdominal pain—Simvastatin—atherosclerosis	0.000193	0.0138	CcSEcCtD
Metyrapone—Headache—Rosuvastatin—atherosclerosis	0.000193	0.0138	CcSEcCtD
Metyrapone—Pain—Niacin—atherosclerosis	0.000192	0.0137	CcSEcCtD
Metyrapone—Pain—Pravastatin—atherosclerosis	0.000189	0.0135	CcSEcCtD
Metyrapone—Gastrointestinal pain—Niacin—atherosclerosis	0.000184	0.0131	CcSEcCtD
Metyrapone—Nausea—Rosuvastatin—atherosclerosis	0.000183	0.0131	CcSEcCtD
Metyrapone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000181	0.0129	CcSEcCtD
Metyrapone—Abdominal pain—Niacin—atherosclerosis	0.000178	0.0127	CcSEcCtD
Metyrapone—Abdominal pain—Pravastatin—atherosclerosis	0.000175	0.0125	CcSEcCtD
Metyrapone—Dizziness—Lovastatin—atherosclerosis	0.000173	0.0123	CcSEcCtD
Metyrapone—Dizziness—Ezetimibe—atherosclerosis	0.00017	0.0121	CcSEcCtD
Metyrapone—Vomiting—Lovastatin—atherosclerosis	0.000166	0.0119	CcSEcCtD
Metyrapone—Headache—Lovastatin—atherosclerosis	0.000164	0.0117	CcSEcCtD
Metyrapone—Vomiting—Ezetimibe—atherosclerosis	0.000163	0.0116	CcSEcCtD
Metyrapone—Dizziness—Simvastatin—atherosclerosis	0.000162	0.0115	CcSEcCtD
Metyrapone—Headache—Ezetimibe—atherosclerosis	0.000161	0.0115	CcSEcCtD
Metyrapone—Vomiting—Simvastatin—atherosclerosis	0.000156	0.0111	CcSEcCtD
Metyrapone—Nausea—Lovastatin—atherosclerosis	0.000155	0.0111	CcSEcCtD
Metyrapone—Headache—Simvastatin—atherosclerosis	0.000153	0.0109	CcSEcCtD
Metyrapone—Nausea—Ezetimibe—atherosclerosis	0.000152	0.0109	CcSEcCtD
Metyrapone—Dizziness—Niacin—atherosclerosis	0.000149	0.0106	CcSEcCtD
Metyrapone—Dizziness—Pravastatin—atherosclerosis	0.000146	0.0104	CcSEcCtD
Metyrapone—Nausea—Simvastatin—atherosclerosis	0.000145	0.0104	CcSEcCtD
Metyrapone—Vomiting—Niacin—atherosclerosis	0.000143	0.0102	CcSEcCtD
Metyrapone—Headache—Niacin—atherosclerosis	0.000141	0.01	CcSEcCtD
Metyrapone—Vomiting—Pravastatin—atherosclerosis	0.000141	0.01	CcSEcCtD
Metyrapone—Headache—Pravastatin—atherosclerosis	0.000139	0.00988	CcSEcCtD
Metyrapone—Nausea—Niacin—atherosclerosis	0.000133	0.00952	CcSEcCtD
Metyrapone—Nausea—Pravastatin—atherosclerosis	0.000131	0.00937	CcSEcCtD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.14e-05	0.00054	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.12e-05	0.000536	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—HMGCR—atherosclerosis	2.09e-05	0.000529	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—NAMPT—atherosclerosis	2.08e-05	0.000526	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP27A1—atherosclerosis	2.07e-05	0.000524	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.07e-05	0.000523	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—LIPC—atherosclerosis	2.07e-05	0.000523	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—APOC3—atherosclerosis	2.05e-05	0.000519	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—LDLR—atherosclerosis	2.04e-05	0.000516	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.04e-05	0.000516	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—APOB—atherosclerosis	2.03e-05	0.000513	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CETP—atherosclerosis	1.99e-05	0.000504	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.99e-05	0.000503	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOA2—atherosclerosis	1.96e-05	0.000497	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALOX5AP—atherosclerosis	1.96e-05	0.000497	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALOX15—atherosclerosis	1.96e-05	0.000497	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PLA2G2A—atherosclerosis	1.96e-05	0.000497	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—LTA4H—atherosclerosis	1.96e-05	0.000495	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCG8—atherosclerosis	1.96e-05	0.000495	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ABCG5—atherosclerosis	1.94e-05	0.00049	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.94e-05	0.00049	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—SCARB1—atherosclerosis	1.91e-05	0.000483	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LDLRAP1—atherosclerosis	1.9e-05	0.00048	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.89e-05	0.000477	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—LPA—atherosclerosis	1.87e-05	0.000474	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ABCA1—atherosclerosis	1.87e-05	0.000472	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.86e-05	0.00047	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—BGN—atherosclerosis	1.81e-05	0.000459	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—HMGCR—atherosclerosis	1.8e-05	0.000456	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.8e-05	0.000455	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOA5—atherosclerosis	1.8e-05	0.000454	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PLTP—atherosclerosis	1.79e-05	0.000451	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.74e-05	0.000441	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PLA2G1B—atherosclerosis	1.73e-05	0.000437	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.71e-05	0.000433	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.71e-05	0.000432	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.69e-05	0.000428	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.69e-05	0.000427	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALOX5—atherosclerosis	1.67e-05	0.000422	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.63e-05	0.000411	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ABCA1—atherosclerosis	1.61e-05	0.000406	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.61e-05	0.000406	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—HMOX1—atherosclerosis	1.6e-05	0.000405	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—TGFB1—atherosclerosis	1.58e-05	0.000398	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCG1—atherosclerosis	1.55e-05	0.000392	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LTA4H—atherosclerosis	1.55e-05	0.000391	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCG8—atherosclerosis	1.55e-05	0.000391	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.54e-05	0.00039	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—APOB—atherosclerosis	1.53e-05	0.000388	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NAMPT—atherosclerosis	1.5e-05	0.000379	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GSTM1—atherosclerosis	1.49e-05	0.000377	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.49e-05	0.000376	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—LIPC—atherosclerosis	1.49e-05	0.000376	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOC3—atherosclerosis	1.48e-05	0.000374	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—LDLR—atherosclerosis	1.47e-05	0.000372	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—LPL—atherosclerosis	1.46e-05	0.00037	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—FABP4—atherosclerosis	1.46e-05	0.000368	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—LCAT—atherosclerosis	1.46e-05	0.000368	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CETP—atherosclerosis	1.44e-05	0.000363	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOA4—atherosclerosis	1.43e-05	0.000361	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GPX1—atherosclerosis	1.43e-05	0.000361	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP7A1—atherosclerosis	1.4e-05	0.000355	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CD36—atherosclerosis	1.39e-05	0.000352	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—HMOX1—atherosclerosis	1.38e-05	0.000349	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—SCARB1—atherosclerosis	1.38e-05	0.000348	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.34e-05	0.000339	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—APOB—atherosclerosis	1.32e-05	0.000334	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—MTHFR—atherosclerosis	1.32e-05	0.000333	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—HMGCR—atherosclerosis	1.3e-05	0.000328	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP27A1—atherosclerosis	1.3e-05	0.000328	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PPARA—atherosclerosis	1.29e-05	0.000327	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GSTM1—atherosclerosis	1.29e-05	0.000325	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ALB—atherosclerosis	1.27e-05	0.000322	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—LPL—atherosclerosis	1.26e-05	0.000319	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AGT—atherosclerosis	1.25e-05	0.000317	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	1.24e-05	0.000314	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GPX1—atherosclerosis	1.23e-05	0.000311	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOA2—atherosclerosis	1.23e-05	0.000311	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PLA2G2A—atherosclerosis	1.23e-05	0.000311	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALOX5AP—atherosclerosis	1.23e-05	0.000311	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALOX15—atherosclerosis	1.23e-05	0.000311	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—APOE—atherosclerosis	1.23e-05	0.00031	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	1.23e-05	0.00031	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCG1—atherosclerosis	1.22e-05	0.000309	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CAV1—atherosclerosis	1.22e-05	0.000307	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCG5—atherosclerosis	1.22e-05	0.000307	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—APOA1—atherosclerosis	1.21e-05	0.000307	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CD36—atherosclerosis	1.2e-05	0.000303	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—LPA—atherosclerosis	1.17e-05	0.000297	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.17e-05	0.000296	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ABCA1—atherosclerosis	1.16e-05	0.000293	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—FABP4—atherosclerosis	1.15e-05	0.000291	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LCAT—atherosclerosis	1.15e-05	0.000291	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—BGN—atherosclerosis	1.14e-05	0.000287	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—MTHFR—atherosclerosis	1.14e-05	0.000287	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOA4—atherosclerosis	1.13e-05	0.000286	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOA5—atherosclerosis	1.13e-05	0.000284	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PPARA—atherosclerosis	1.11e-05	0.000282	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP7A1—atherosclerosis	1.11e-05	0.000281	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CG—atherosclerosis	1.11e-05	0.00028	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PLA2G1B—atherosclerosis	1.08e-05	0.000274	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AGT—atherosclerosis	1.08e-05	0.000273	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PPARG—atherosclerosis	1.07e-05	0.00027	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—APOE—atherosclerosis	1.06e-05	0.000267	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—INS—atherosclerosis	1.05e-05	0.000265	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CAV1—atherosclerosis	1.05e-05	0.000265	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALOX5—atherosclerosis	1.05e-05	0.000264	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—APOA1—atherosclerosis	1.05e-05	0.000264	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP27A1—atherosclerosis	1.03e-05	0.000259	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—HMOX1—atherosclerosis	9.93e-06	0.000251	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOA2—atherosclerosis	9.72e-06	0.000246	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PLA2G2A—atherosclerosis	9.72e-06	0.000246	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALOX15—atherosclerosis	9.72e-06	0.000246	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALOX5AP—atherosclerosis	9.72e-06	0.000246	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ALB—atherosclerosis	9.61e-06	0.000243	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCG5—atherosclerosis	9.6e-06	0.000243	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CG—atherosclerosis	9.54e-06	0.000241	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOB—atherosclerosis	9.51e-06	0.00024	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NAMPT—atherosclerosis	9.38e-06	0.000237	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—LIPC—atherosclerosis	9.32e-06	0.000236	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LPA—atherosclerosis	9.28e-06	0.000234	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOC3—atherosclerosis	9.27e-06	0.000234	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTM1—atherosclerosis	9.25e-06	0.000234	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PPARG—atherosclerosis	9.21e-06	0.000233	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—LDLR—atherosclerosis	9.21e-06	0.000233	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—NOS3—atherosclerosis	9.19e-06	0.000232	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—LPL—atherosclerosis	9.08e-06	0.00023	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—INS—atherosclerosis	9.03e-06	0.000228	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CETP—atherosclerosis	9e-06	0.000227	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—BGN—atherosclerosis	8.98e-06	0.000227	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOA5—atherosclerosis	8.89e-06	0.000225	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GPX1—atherosclerosis	8.86e-06	0.000224	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	8.81e-06	0.000223	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CD36—atherosclerosis	8.63e-06	0.000218	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SCARB1—atherosclerosis	8.62e-06	0.000218	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PLA2G1B—atherosclerosis	8.56e-06	0.000216	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTGS2—atherosclerosis	8.41e-06	0.000213	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLTP—atherosclerosis	8.29e-06	0.000209	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ALB—atherosclerosis	8.28e-06	0.000209	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALOX5—atherosclerosis	8.27e-06	0.000209	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—MTHFR—atherosclerosis	8.18e-06	0.000207	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HMGCR—atherosclerosis	8.14e-06	0.000206	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PPARA—atherosclerosis	8.02e-06	0.000203	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—NOS3—atherosclerosis	7.92e-06	0.0002	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AGT—atherosclerosis	7.77e-06	0.000196	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOE—atherosclerosis	7.61e-06	0.000192	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CAV1—atherosclerosis	7.54e-06	0.000191	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOA1—atherosclerosis	7.53e-06	0.00019	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NAMPT—atherosclerosis	7.42e-06	0.000187	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LIPC—atherosclerosis	7.37e-06	0.000186	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOC3—atherosclerosis	7.32e-06	0.000185	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LDLR—atherosclerosis	7.28e-06	0.000184	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCA1—atherosclerosis	7.25e-06	0.000183	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTGS2—atherosclerosis	7.25e-06	0.000183	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCG8—atherosclerosis	7.18e-06	0.000182	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LTA4H—atherosclerosis	7.18e-06	0.000182	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CETP—atherosclerosis	7.11e-06	0.00018	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CG—atherosclerosis	6.87e-06	0.000174	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SCARB1—atherosclerosis	6.81e-06	0.000172	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PPARG—atherosclerosis	6.63e-06	0.000168	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—INS—atherosclerosis	6.5e-06	0.000164	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HMGCR—atherosclerosis	6.43e-06	0.000163	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HMOX1—atherosclerosis	6.22e-06	0.000157	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALB—atherosclerosis	5.96e-06	0.000151	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOB—atherosclerosis	5.96e-06	0.000151	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTM1—atherosclerosis	5.8e-06	0.000147	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCA1—atherosclerosis	5.73e-06	0.000145	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NOS3—atherosclerosis	5.7e-06	0.000144	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—LPL—atherosclerosis	5.69e-06	0.000144	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCG1—atherosclerosis	5.68e-06	0.000144	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GPX1—atherosclerosis	5.55e-06	0.00014	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CD36—atherosclerosis	5.41e-06	0.000137	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LCAT—atherosclerosis	5.34e-06	0.000135	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—FABP4—atherosclerosis	5.34e-06	0.000135	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOA4—atherosclerosis	5.24e-06	0.000132	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTGS2—atherosclerosis	5.22e-06	0.000132	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	5.15e-06	0.00013	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MTHFR—atherosclerosis	5.12e-06	0.00013	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPARA—atherosclerosis	5.03e-06	0.000127	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HMOX1—atherosclerosis	4.92e-06	0.000124	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AGT—atherosclerosis	4.87e-06	0.000123	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOE—atherosclerosis	4.77e-06	0.000121	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	4.76e-06	0.00012	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CAV1—atherosclerosis	4.73e-06	0.000119	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOA1—atherosclerosis	4.71e-06	0.000119	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOB—atherosclerosis	4.71e-06	0.000119	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTM1—atherosclerosis	4.58e-06	0.000116	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	4.51e-06	0.000114	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALOX15—atherosclerosis	4.51e-06	0.000114	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOA2—atherosclerosis	4.51e-06	0.000114	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	4.51e-06	0.000114	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LPL—atherosclerosis	4.5e-06	0.000114	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCG5—atherosclerosis	4.46e-06	0.000113	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GPX1—atherosclerosis	4.39e-06	0.000111	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CG—atherosclerosis	4.3e-06	0.000109	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LPA—atherosclerosis	4.3e-06	0.000109	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CD36—atherosclerosis	4.27e-06	0.000108	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AKT1—atherosclerosis	4.23e-06	0.000107	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—BGN—atherosclerosis	4.17e-06	0.000105	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPARG—atherosclerosis	4.15e-06	0.000105	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOA5—atherosclerosis	4.13e-06	0.000104	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—INS—atherosclerosis	4.07e-06	0.000103	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MTHFR—atherosclerosis	4.05e-06	0.000102	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPARA—atherosclerosis	3.97e-06	0.0001	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.97e-06	0.0001	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AGT—atherosclerosis	3.85e-06	9.72e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.84e-06	9.7e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOE—atherosclerosis	3.77e-06	9.53e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALB—atherosclerosis	3.74e-06	9.44e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CAV1—atherosclerosis	3.73e-06	9.44e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOA1—atherosclerosis	3.73e-06	9.42e-05	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AKT1—atherosclerosis	3.64e-06	9.21e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NOS3—atherosclerosis	3.57e-06	9.03e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.44e-06	8.7e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LIPC—atherosclerosis	3.42e-06	8.64e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CG—atherosclerosis	3.4e-06	8.6e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOC3—atherosclerosis	3.4e-06	8.59e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LDLR—atherosclerosis	3.38e-06	8.54e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CETP—atherosclerosis	3.3e-06	8.34e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPARG—atherosclerosis	3.28e-06	8.3e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTGS2—atherosclerosis	3.27e-06	8.26e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—INS—atherosclerosis	3.22e-06	8.14e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.16e-06	7.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.98e-06	7.54e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALB—atherosclerosis	2.95e-06	7.46e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NOS3—atherosclerosis	2.82e-06	7.14e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.66e-06	6.72e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AKT1—atherosclerosis	2.62e-06	6.63e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTGS2—atherosclerosis	2.58e-06	6.53e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.28e-06	5.77e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOB—atherosclerosis	2.18e-06	5.52e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.13e-06	5.37e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LPL—atherosclerosis	2.09e-06	5.27e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GPX1—atherosclerosis	2.04e-06	5.15e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CD36—atherosclerosis	1.98e-06	5.01e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.88e-06	4.75e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPARA—atherosclerosis	1.84e-06	4.66e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AGT—atherosclerosis	1.78e-06	4.51e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOE—atherosclerosis	1.75e-06	4.42e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CAV1—atherosclerosis	1.73e-06	4.38e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOA1—atherosclerosis	1.73e-06	4.37e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKT1—atherosclerosis	1.64e-06	4.15e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.58e-06	3.99e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPARG—atherosclerosis	1.52e-06	3.85e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—INS—atherosclerosis	1.49e-06	3.78e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALB—atherosclerosis	1.37e-06	3.46e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NOS3—atherosclerosis	1.31e-06	3.31e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKT1—atherosclerosis	1.3e-06	3.28e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.2e-06	3.03e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKT1—atherosclerosis	6.02e-07	1.52e-05	CbGpPWpGaD
